Neurology market to be valued at $94.8b by 2029

Its growth is attributed to the increased prevalence of chronic neurological conditions.

The neurology market is expected to reach $94.8b by 2029, up from $2024, at a compound annual growth rate of 7.1%., according to BCC Research LLC.

The sector’s expansion is attributed to the increased prevalence of neurological conditions such as stroke, Alzheimer's disease, other dementias, and meningitis.

Meanwhile, prevalent neurological disorders include cerebrovascular, neurodegenerative, autoimmune, spinal cord issues, intracranial tumours, and craniocerebral trauma.

“The growing incidence of these conditions, alongside government initiatives and ongoing research, drives market growth in the neurological field,” the report said.